Nephros (NEPH) closed at $3.27 on October 29, 2026, up 3.2% from the previous close, on volume of 72,408 shares (30-day average 43,469).
Data as of October 29, 2026.
No headlines found.
Nephros Schedules Third Quarter 2026 Financial Results Conference Call
Globe Newswire (Thu, 29-Oct 4:30 PM ET)
Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
Globe Newswire (Thu, 6-Aug 4:10 PM ET)
Nephros Schedules Second Quarter 2026 Financial Results Conference Call
Globe Newswire (Wed, 5-Aug 4:00 PM ET)
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
Nephros trades on the NASDAQ stock market under the symbol NEPH.
As of October 29, 2026, NEPH stock price climbed to $3.27 with 72,408 million shares trading.
NEPH has a beta of 1.44, meaning it tends to be more sensitive to market movements. NEPH has a correlation of 0.07 to the broad based SPY ETF.
NEPH has a market cap of $35.54 million. This is considered a Sub-Micro Cap stock.
Last quarter Nephros reported $6 million in Revenue and $.11 earnings per share. This beat revenue expectation by $966,500 and exceeded earnings estimates by $.12.
In the last 3 years, NEPH traded as high as $6.42 and as low as $1.36.
The top ETF exchange traded funds that NEPH belongs to (by Net Assets): VTI, VXF, IWC, DFAC, DCOR.
NEPH has underperformed the market in the last year with a price return of -43.0% while the SPY ETF gained +13.1%. NEPH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.6% and -7.1%, respectively, while the SPY returned +4.1% and 0.0%, respectively.
NEPH support price is $2.95 and resistance is $3.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NEPH shares will trade within this expected range on the day.
